Atrial Fibrillation Rate Control

Introduction to Rate Control

• Beta blockers are the most effective drug class for rate control, achieving heart rate endpoints in 70% of patients compared to 54% with calcium channel blockers, and provide excellent control of both resting and exercise-induced tachycardia in AF patients 1

Patient Selection and Dosing

• The American College of Cardiology recommends beta blockers as first-line agents for rate control in atrial fibrillation, with a target heart rate of 60-80 bpm at rest, <110 bpm with moderate activity 2
• Beta blockers should be initiated cautiously in patients with heart failure with reduced ejection fraction, asthma or COPD, bradycardia or heart block, or hypotension 1, 2

Contraindications and Alternative Therapies

• Absolute contraindications to beta blockers include severe bradycardia, high-grade AV block without pacemaker, cardiogenic shock, and decompensated heart failure 2
• If beta blockers are ineffective or contraindicated, consider non-dihydropyridine calcium channel blockers (diltiazem, verapamil), digoxin, or amiodarone as alternative therapies 1, 3

Monitoring and Titration

• Monitor heart rate, blood pressure, and symptoms with either dosing schedule, and titrate doses gradually (typically every 1-2 weeks) based on patient response 2

Goals of Rate Control

• The primary goal of rate control is to improve symptoms and quality of life while preventing tachycardia-induced cardiomyopathy, rather than achieving a specific heart rate target 2